| 期 |
标题 |
文件 |
| 卷 93, 编号 1 (2021) |
Calcification and atherosclerosis of the coronary arteries |
(Rus)
|
|
Kashtanova E., Polonskaya Y., Ragino Y.
|
| 卷 93, 编号 1 (2021) |
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes |
(Rus)
|
|
Verner V., Mel’nik M., Knjazeva S.
|
| 卷 92, 编号 11 (2020) |
Risks of oncologic pathology in parasitosis at the present time |
(Rus)
|
|
Omarova K., Aleshina N., Ponezhevа Z., Gorelov A., Maleev V., Akimkin V.
|
| 卷 92, 编号 11 (2020) |
Current view on Blastocystis species: clinical forms, diagnosis and treatment |
(Rus)
|
|
Maleev V., Tokmalaev A., Kozhevnikova G., Tsvetkova N., Polovinkina N., Golub V., Maksimova M., Barysheva I., Konnov V., Kharlamova T.
|
| 卷 92, 编号 11 (2020) |
Umifenovir and coronavirus infections: a review of research results and clinical practice |
(Rus)
|
|
Leneva I., Pshenichnaya N., Bulgakova V.
|
| 卷 92, 编号 11 (2020) |
The role of vitamin D in seasonal acute respiratory viral infections and COVID-19 |
(Rus)
|
|
Pigarova E., Povalyaeva A., Dzeranova L., Rozhinskaya L., Mokrysheva N.
|
| 卷 92, 编号 11 (2020) |
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria |
(Rus)
|
|
Sturov N., Popov S., Mamporia N., Mager A.
|
| 卷 92, 编号 11 (2020) |
The problem of global development of antibiotic resistant nosocomial pathogens |
(Rus)
|
|
Gabrielyan N., Sharapchenko S., Kisil О., Kormilitsina V., Drabkina I., Safonova Т., Petrukhina М., Saitgareev R., Zakharevich V.
|
| 卷 92, 编号 11 (2020) |
Opportunities for use the cascade model of medical care for people living with HIV |
(Rus)
|
|
Pokrovskaya A., Pokrovskiy V., Akimkin V.
|
| 卷 92, 编号 11 (2020) |
Epidemiological and clinical aspects of diagnosis, treatment and prophylaxis of imported malaria cases in Russian Federation |
(Rus)
|
|
Tokmalaev A., Baranova A., Maleev V.
|
| 卷 92, 编号 10 (2020) |
The prevalence of autoimmune endocrine diseases in vitiligo patients |
(Rus)
|
|
Troshina E., Volnukhin V., Petrov V., Nuralieva N., Yukina M., Orlova E., Frigo N.
|
| 卷 92, 编号 10 (2020) |
Gut microbiota is a factor of risk for obesity and type 2 diabetes |
(Rus)
|
|
Demidova T., Lobanova K., Oinotkinova O.
|
| 卷 92, 编号 9 (2020) |
Choosing of therapy for a patient with dorsalgia |
(Rus)
|
|
Kamchatnov P., Abusueva B., Khanmurzaeva S., Khanmurzaeva N.
|
| 卷 92, 编号 9 (2020) |
Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention |
(Rus)
|
|
Oynotkinova O., Nikonov E., Demidova T., Baranov A., Kryukov E., Dedov E., Karavashkina E.
|
| 卷 92, 编号 9 (2020) |
Diagnostic and prognostic significance of QRS-T angle |
(Rus)
|
|
Blinova E., Sakhnova T., Yurasova E.
|
| 卷 92, 编号 9 (2020) |
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat |
(Rus)
|
|
Gratsianskaya S., Valieva Z., Martynyuk T.
|
| 卷 92, 编号 9 (2020) |
Role of magnetic resonance imaging in patients with aortic stenosis before and after replacement of the valve |
(Rus)
|
|
Shariya M., Ustyuzhanin D., Lepilin P., Imaev T., Komlev A., Belyaevskaya A., Ternovoy S.
|
| 卷 92, 编号 9 (2020) |
Hypertrophic cardiomyopathy in elderly: causes, diagnostic and treatment approaches |
(Rus)
|
|
Chumakova O.
|
| 卷 92, 编号 9 (2020) |
Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension |
(Rus)
|
|
Aleevskaya A., Vyborov O., Gramovich V., Martynyuk T.
|
| 卷 92, 编号 9 (2020) |
Decreasing cardiovascular morbidity: how to improve adherence to the treatment in the translational era |
(Rus)
|
|
Zhirov I.
|
| 卷 92, 编号 8 (2020) |
Diet therapy for irritable bowel syndrome |
(Rus)
|
|
Bakulin I., Avalueva E., Оrеshkо L., Sitkin S., Shevyakov M., Serkova M., Semenova E.
|
| 卷 92, 编号 8 (2020) |
Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals |
(Rus)
|
|
Trukhmanov A., Makushina A., Storonova O., Ivashkina N.
|
| 卷 95, 编号 9 (2023) |
Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review |
(Rus)
|
|
Zhirov I., Safronova N., Tereshchenko S.
|
| 卷 95, 编号 9 (2023) |
Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review |
(Rus)
|
|
Zakiev V., Kotovskaya Y., Tkacheva O.
|
| 151 - 174 的 174 信息 |
<< < 1 2 3 4
|
